# Sansei Capital Investment

Sansei Capital Investment is a Venture Capital based in Tokyo, Japan.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Tokyo, Japan
- **Address:** Tokyo, Japan
- **Assets under management:** $104 million
- **Website:** www.sanseicapital.com

## Regulatory record

- **Reports private funds:** No

## About

Sansei Capital Investment is a venture capital firm headquartered in Tokyo, Japan, and a subsidiary of Taiju Life Insurance. The firm manages $104 million in assets under management. Sansei Capital has made 59 investments to date, demonstrating active deployment across venture-stage opportunities. Notable investments include a Series A round in RABO completed on April 6, 2021. The firm has achieved 17 portfolio exits, including J-Pharma, which exited on March 25, 2026. Through its relationship with Taiju Life Insurance, Sansei Capital leverages corporate backing to support its venture investment activities. The firm's track record reflects engagement across multiple stages of venture funding.

## Sectors

- Venture Capital
- Japan

## Questions

### What is Sansei Capital Investment?

Sansei Capital Investment is a venture capital subsidiary of Taiju Life Insurance, headquartered in Tokyo, Japan, with $104 million in assets under management.

### How many investments has Sansei Capital made?

Sansei Capital has made 59 investments, including a Series A investment in RABO on April 6, 2021.

### How many exits does Sansei Capital have?

Sansei Capital has completed 17 portfolio exits, including J-Pharma, which exited on March 25, 2026.

---

Last updated: 2026-07-13T04:52:40.000Z

Canonical page: https://altss.com/profile/sansei-capital-investment

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology